Correlation Between Galera Therapeutics and Abpro Holdings
Can any of the company-specific risk be diversified away by investing in both Galera Therapeutics and Abpro Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Galera Therapeutics and Abpro Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Galera Therapeutics and Abpro Holdings, you can compare the effects of market volatilities on Galera Therapeutics and Abpro Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Galera Therapeutics with a short position of Abpro Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Galera Therapeutics and Abpro Holdings.
Diversification Opportunities for Galera Therapeutics and Abpro Holdings
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Galera and Abpro is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Galera Therapeutics and Abpro Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abpro Holdings and Galera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Galera Therapeutics are associated (or correlated) with Abpro Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abpro Holdings has no effect on the direction of Galera Therapeutics i.e., Galera Therapeutics and Abpro Holdings go up and down completely randomly.
Pair Corralation between Galera Therapeutics and Abpro Holdings
Given the investment horizon of 90 days Galera Therapeutics is expected to generate 22.3 times less return on investment than Abpro Holdings. But when comparing it to its historical volatility, Galera Therapeutics is 6.87 times less risky than Abpro Holdings. It trades about 0.04 of its potential returns per unit of risk. Abpro Holdings is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 5.99 in Abpro Holdings on October 4, 2024 and sell it today you would earn a total of 0.26 from holding Abpro Holdings or generate 4.34% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 55.23% |
Values | Daily Returns |
Galera Therapeutics vs. Abpro Holdings
Performance |
Timeline |
Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Abpro Holdings |
Galera Therapeutics and Abpro Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Galera Therapeutics and Abpro Holdings
The main advantage of trading using opposite Galera Therapeutics and Abpro Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Galera Therapeutics position performs unexpectedly, Abpro Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abpro Holdings will offset losses from the drop in Abpro Holdings' long position.Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Abpro Holdings vs. Vaccinex | Abpro Holdings vs. Dogwood Therapeutics, | Abpro Holdings vs. Eupraxia Pharmaceuticals Common | Abpro Holdings vs. CERo Therapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world |